PTSM: Pharmaceutical Technology Sourcing and Management, Jun 2, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Jun 2, 2011
APIs
Global Pharma Market Expected to Reach $1 Trillion
By Patricia Van Arnum
The global pharmaceutical market is expected to reach sales of nearly $1.1 trillion by 2015, marked by slowing growth in developed markets and strong sales in emerging markets.
Sourcing
Innovation in Sourcing
By Patricia Van Arnum
Industry experts share perspectives on value creation in sourcing, procurement, and external development and manufacturing.
Outsourcing
Supply Chain Pain
By Jim Miller
Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.
CSR and Sustainability Forum
IFPMA Outlines Global Health Initiatives
By Patricia Van Arnum
Eduardo Pisani, director general of the International Federation of Pharmaceutical Manufacturers & Associations, discusses the global health initiatives and related activities of the association.
WHO Meeting Produces Several Action and Policy Items
By Patricia Van Arnum
The World Health Assembly, the decision-making body of the World Health Organization, met in Geneva last month to discuss and take action on initiatives relating to influenza pandemic preparedness, noncommunicable diseases, and the health-related UN Millennium Development Goals.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here